Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LY038
- Development stage
- Unknown
- Lead developer
- Svalöf Weibull
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Administration
- Subcutaneous
01
Overview
LY038 is a biosimilar candidate of teriparatide, a recombinant form of the human parathyroid hormone (residues 1-34). Developed by Luye Pharma (specifically its subsidiary Boan Biotech), LY038 is intended for the treatment of osteoporosis in postmenopausal women at high risk of fracture. Teriparatide acts as an anabolic agent that stimulates bone formation by binding to the parathyroid hormone receptor 1 (PTH1R). When administered intermittently at low doses, it promotes osteoblastic activity more than osteoclastic activity, leading to an increase in bone mineral density and improved bone strength. LY038 is designed to be highly similar to the reference product, Forteo, in terms of safety, efficacy, and quality.
- Other names
- teriparatide biosimilarrecombinant human parathyroid hormone (1-34) injection
02
Targets
PTH1R (Parathyroid hormone/Parathyroid hormone-related peptide receptor type 1)
Beyond the preview
Go deeper on LY038.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LY038.